Results
8523
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,523 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A257720 | ₩31,750.00 | -6.3% | 294.9% | ₩1.9t | ₩56,750.00 | PE19.7x | E41.7% | n/a | Retail | ||
CUV | AU$11.84 | -0.3% | -24.3% | AU$591.4m | AU$28.23 | PE16.6x | E26.2% | 0.4% | Pharmaceuticals & Biotech | ||
FND | AU$4.42 | 17.6% | 233.6% | AU$217.0m | AU$9.00 | PS3.3x | E110.7% | n/a | Diversified Financials | ||
FWRY | ج.م8.50 | 1.1% | 55.7% | ج.م29.4b | ج.م12.45 | PE23.4x | E27.4% | n/a | Diversified Financials | ||
RMDA | ج.م3.35 | 2.1% | 79.1% | ج.م5.1b | ج.م5.02 | PE18.9x | E30.7% | 2.0% | Pharmaceuticals & Biotech | ||
BBT | AU$0.36 | 14.3% | 50.0% | AU$203.8m | AU$0.37 | PS3.5x | E91.4% | n/a | Consumer Services | ||
PLT | AU$0.76 | 0.7% | 20.6% | AU$133.6m | AU$1.50 | PS1.6x | E120.1% | n/a | Diversified Financials | ||
A204270 | ₩23,350.00 | 5.7% | 97.7% | ₩1.3t | ₩24,500.00 | PS3.9x | E104.4% | n/a | Tech | ||
SKS | AU$2.15 | -3.2% | 667.9% | AU$241.0m | AU$2.15 | PE36.4x | E24.8% | 0.5% | Capital Goods | ||
BOE | AU$3.17 | 10.8% | -43.2% | AU$1.3b | AU$4.11 | PE29.1x | E31.9% | n/a | Energy | ||
A178320 | ₩24,900.00 | 2.3% | 27.2% | ₩1.4t | ₩39,333.33 | PE15.1x | E39.9% | 0% | Tech | ||
DGC | ₫111,400.00 | 1.5% | 25.3% | ₫42.3t | ₫132,975.00 | PE15.3x | E23.8% | 5.4% | Materials | ||
9958 | NT$160.50 | 2.9% | -28.7% | NT$41.2b | NT$238.00 | PE19.6x | E44.9% | 1.9% | Materials | ||
ZVRA | US$8.04 | -0.1% | 30.3% | US$429.1m | US$20.63 | PS17.5x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$60.15 | 3.7% | 118.8% | US$19.3b | US$61.85 | PE138.5x | E29.7% | n/a | Consumer Durables | ||
ALNY | US$278.76 | 13.2% | 54.0% | US$36.0b | US$299.71 | PS17.2x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
KINS | US$15.23 | -0.9% | 375.9% | US$188.1m | US$18.00 | PE11.9x | E24.9% | 0% | Insurance | ||
AXSM | US$103.11 | 12.2% | 11.6% | US$5.0b | US$133.56 | PS14.8x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$42.23 | 15.4% | 152.1% | CA$1.6b | CA$45.92 | PE26.4x | E38.9% | 1.4% | Diversified Financials | ||
NVDA | US$142.62 | 3.6% | 128.3% | US$3.5t | US$173.08 | PE55.4x | E24.5% | 0.03% | Semiconductors | ||
TVTX | US$20.31 | 10.6% | 117.9% | US$1.8b | US$28.20 | PS8.7x | E62.1% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$1.67 | 8.4% | 38.0% | CA$429.3m | CA$3.47 | PS1.8x | E107.8% | n/a | Materials | ||
A067310 | ₩11,100.00 | 4.1% | -52.8% | ₩669.3b | ₩18,159.42 | PS0.6x | E119.4% | 0.4% | Semiconductors | ||
BTR | AU$0.021 | 0% | 75.0% | AU$149.8m | AU$0.051 | PS142.1x | E84.1% | n/a | Materials |